133 related articles for article (PubMed ID: 8061893)
1. Overexpression of p53 protein in squamous cell carcinomas of head and neck without apparent gene mutations.
Xu L; Chen YT; Huvos AG; Zlotolow IM; Rettig WJ; Old LJ; Garin-Chesa P
Diagn Mol Pathol; 1994 Jun; 3(2):83-92. PubMed ID: 8061893
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical vs molecular biology methods. Complementary techniques for effective screening of p53 alterations in head and neck cancer.
Calzolari A; Chiarelli I; Bianchi S; Messerini L; Gallo O; Porfirio B; Mattiuz PL
Am J Clin Pathol; 1997 Jan; 107(1):7-11. PubMed ID: 8980360
[TBL] [Abstract][Full Text] [Related]
3. p53 mutations in chondrosarcoma.
Terek RM; Healey JH; Garin-Chesa P; Mak S; Huvos A; Albino AP
Diagn Mol Pathol; 1998 Feb; 7(1):51-6. PubMed ID: 9646035
[TBL] [Abstract][Full Text] [Related]
4. Correlation between p53 immunostaining patterns and gene sequence mutations in breast carcinoma.
Visscher DW; Sarkar FH; Shimoyama RK; Crissman JD
Diagn Mol Pathol; 1996 Sep; 5(3):187-93. PubMed ID: 8866232
[TBL] [Abstract][Full Text] [Related]
5. High frequency of p53 gene alterations associated with protein overexpression in human squamous cell carcinoma of the larynx.
Maestro R; Dolcetti R; Gasparotto D; Doglioni C; Pelucchi S; Barzan L; Grandi E; Boiocchi M
Oncogene; 1992 Jun; 7(6):1159-66. PubMed ID: 1594246
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical detection of p53 protein accumulation in head and neck cancer: correlation with p53 gene alterations.
Taylor D; Koch WM; Zahurak M; Shah K; Sidransky D; Westra WH
Hum Pathol; 1999 Oct; 30(10):1221-5. PubMed ID: 10534171
[TBL] [Abstract][Full Text] [Related]
7. p53 mutation, but not p53 overexpression, correlates with survival in head and neck squamous cell carcinoma.
Mineta H; Borg A; Dictor M; Wahlberg P; Akervall J; Wennerberg J
Br J Cancer; 1998 Oct; 78(8):1084-90. PubMed ID: 9792155
[TBL] [Abstract][Full Text] [Related]
8. Changes of mutant-type p53 expression in squamous cell carcinoma of the head and neck during radiation therapy and its clinical significance: comparison of an immunohistochemical method and PCR-SSCP assay.
Ogawa Y; Nishioka A; Hamada N; Terashima M; Inomata T; Yoshida S; Seguchi H; Kishimoto S
Oncol Rep; 1998; 5(5):1053-9. PubMed ID: 9683807
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of p53 protein is common in premalignant head and neck lesions.
Pavelic ZP; Li YQ; Stambrook PJ; McDonald JS; Munck-Wikland E; Pavelic K; Dacic S; Danilovic Z; Pavelic L; Mugge RE
Anticancer Res; 1994; 14(5B):2259-66. PubMed ID: 7840533
[TBL] [Abstract][Full Text] [Related]
10. Sequencing analysis of RNA and DNA of exons 1 through 11 shows p53 gene alterations to be present in almost 100% of head and neck squamous cell cancers.
Kropveld A; Rozemuller EH; Leppers FG; Scheidel KC; de Weger RA; Koole R; Hordijk GJ; Slootweg PJ; Tilanus MG
Lab Invest; 1999 Mar; 79(3):347-53. PubMed ID: 10092071
[TBL] [Abstract][Full Text] [Related]
11. TP53 gene mutations and CCND1 gene amplification in head and neck squamous cell carcinoma cell lines.
Xu L; Davidson BJ; Murty VV; Li RG; Sacks PG; Garin-Chesa P; Schantz SP; Chaganti RS
Int J Cancer; 1994 Nov; 59(3):383-7. PubMed ID: 7927946
[TBL] [Abstract][Full Text] [Related]
12. p53 immunoreactivity and single-strand conformational polymorphism analysis often fail to predict p53 mutational status.
Tolbert DM; Noffsinger AE; Miller MA; DeVoe GW; Stemmermann GN; Macdonald JS; Fenoglio-Preiser CM
Mod Pathol; 1999 Jan; 12(1):54-60. PubMed ID: 9950163
[TBL] [Abstract][Full Text] [Related]
13. p53 alterations in colon tumors: a comparison of SSCP/sequencing and immunohistochemistry.
Curtin K; Slattery ML; Holubkov R; Edwards S; Holden JA; Samowitz WS
Appl Immunohistochem Mol Morphol; 2004 Dec; 12(4):380-6. PubMed ID: 15536342
[TBL] [Abstract][Full Text] [Related]
14. p53 mutations, protein expression and cell proliferation in squamous cell carcinomas of the head and neck.
Nylander K; Nilsson P; Mehle C; Roos G
Br J Cancer; 1995 Apr; 71(4):826-30. PubMed ID: 7710950
[TBL] [Abstract][Full Text] [Related]
15. p53 mutations and overexpression in locally advanced breast cancers.
Faille A; De Cremoux P; Extra JM; Linares G; Espie M; Bourstyn E; De Rocquancourt A; Giacchetti S; Marty M; Calvo F
Br J Cancer; 1994 Jun; 69(6):1145-50. PubMed ID: 8198984
[TBL] [Abstract][Full Text] [Related]
16. Implications of p53 alterations and anti-p53 antibody response in head and neck squamous cell carcinomas.
Lavieille JP; Righini C; Reyt E; Brambilla C; Riva C
Oral Oncol; 1998 Mar; 34(2):84-92. PubMed ID: 9682769
[TBL] [Abstract][Full Text] [Related]
17. High levels of the p53 inhibitor MDM4 in head and neck squamous carcinomas.
Valentin-Vega YA; Barboza JA; Chau GP; El-Naggar AK; Lozano G
Hum Pathol; 2007 Oct; 38(10):1553-62. PubMed ID: 17651783
[TBL] [Abstract][Full Text] [Related]
18. P53 expression, p53 and Ha-ras mutation and telomerase activation during nitrosamine-mediated hamster pouch carcinogenesis.
Chang KW; Sarraj S; Lin SC; Tsai PI; Solt D
Carcinogenesis; 2000 Jul; 21(7):1441-51. PubMed ID: 10874024
[TBL] [Abstract][Full Text] [Related]
19. Gene mutations and increased levels of p53 protein in human squamous cell carcinomas and their cell lines.
Burns JE; Baird MC; Clark LJ; Burns PA; Edington K; Chapman C; Mitchell R; Robertson G; Soutar D; Parkinson EK
Br J Cancer; 1993 Jun; 67(6):1274-84. PubMed ID: 8390283
[TBL] [Abstract][Full Text] [Related]
20. P53 overexpression in epidermoid carcinoma of the head and neck.
Logullo AF; Kowalski LP; Nonogaki S; Miguel RE; Torloni H; Brentani RR
Sao Paulo Med J; 1997; 115(1):1349-55. PubMed ID: 9293116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]